Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Owc Pharmaceutical Research's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Owc Pharmaceutical Research (OWCP) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q3 2019

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/OWCP/competitors
https://api.csimarket.com/api/v1/companies/OWCP/relationships
https://api.csimarket.com/api/v1/companies/OWCP/similar
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API

Owc Pharmaceutical Research's Competitor Quality Breadth

Group definitions: see Methodology: Performance Group Definitions.

Entity Profitable Expanding Above Industry Growth Distressed
Owc Pharmaceutical Research Corp. - - - Yes
High-Confidence Competitors (1) - - - 0%

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

OWCP Stock Performance relative to its Competitors

OWCP Competitors (weighted) Percent change over the selected range

Owc Pharmaceutical Research's Share Price Performance vs Peer Groups

Trailing 12-month total share price return, and the share of each group that outperformed the U.S.A. 500 over the same period. Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC.
0%beat U.S.A. 500
High-Confidence
(0 of 1)
Entity TTM Share Price Return
(group: median)
vs U.S.A. 500
Owc Pharmaceutical Research Corp. 0.00 % Underperformed
Competitors combined (0) 40.4% 63.2%
High-Confidence Competitors (1) 40.4% 63.2%
Similar-Size Competitors (0) 40.4% 63.2%
Similar Growth & Profitability (0) 40.4% 63.2%
Peer Group Share Price Returns

TTM share price return and U.S.A. 500 outperformance for Owc Pharmaceutical Research's competitor groups requires a Commercial License.

Source: CSIMarket API (daily market-structure computation). Outperformance is trailing-12-month total return vs the U.S.A. 500 over the same window, not risk-adjusted.

OWCP Stock Performance relative to High-Confidence Competitors

OWCP High-Confidence Competitors (equal-weighted, 1) Percent change over the selected range
Competitor data is not yet available for Owc Pharmaceutical Research.

Owc Pharmaceutical Research's Competitors Named by the Company

Competitive relationships identified from Owc Pharmaceutical Research reports and corroborating sources, each with a basis and confidence.
Competitor Basis Confidence Active Sources
Pharmacyte Biotech Inc Company report 85% 2022 to 2026 3
Competitor Evidence Detail

Company report basis, confidence, active dates and source counts for Owc Pharmaceutical Research's named competitors require a Commercial License.

Methodology: see Methodology: Peer & Competitor Identification, Sourcing.

Get the full CSIMarket dataset: Subscribe API Connect Your AI